Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT

BACKGROUND: Chronic active Epstein-Barr virus infection (CAEBV) is a rare but life-threatening progressive disease. Human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is the best choice as sometimes HLA-matched donor is not accessible. However, graft-ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Rongmu, Zhang, Xiaomei, Wang, Ya, Man, Qihang, Gu, Wenjing, Tian, Zhengqin, Wang, Jingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716678/
https://www.ncbi.nlm.nih.gov/pubmed/36461028
http://dx.doi.org/10.1186/s13023-022-02585-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716678/
https://www.ncbi.nlm.nih.gov/pubmed/36461028
http://dx.doi.org/10.1186/s13023-022-02585-2

Ejemplares similares